Evidence map›Paper›PMID 40290054›Full record

ReviewJournal of evaluation in clinical practice2025

Digital Tools to Support the Systematic Review Process: An Introduction.

Lena Schmidt, Ian Cree, Fiona Campbell, WCT EVI MAP group

Abstract readReview
In one paragraph

Review in Journal of evaluation in clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Evaluating AI Performance in Systematic Literature Reviews for HEOR: A Case Study.Journal of health economics and outcomes research · 2026
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lena SchmidtNational Institute for Health and Care Research Innovation Observatory, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0003-0709-8226
Ian CreeInternational Agency for Research on Cancer, Lyon, France.
Fiona CampbellNational Institute for Health and Care Research Innovation Observatory, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0002-4141-8863
WCT EVI MAP group

Funding

Fiona Campbell and Lena Schmidt were supported by the National Institute for Health and Care Research (NIHR) [HSRIC-2016-10009/Innovation Observatory]. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. This publication through the EVI MAP project is funded by the European Union (HORIZON Grant No 101057127).World Health Organization 001
6 · The paper itself

Abstract

backgroundThe introduction of systematic reviews in medicine has prompted a paradigm shift in employing evidence for decision-making across various fields. Its methodology involves structured comparisons, critical appraisals, and pooled data analysis to inform decision-making. The process itself is resource-intensive and time-consuming which can impede the timely incorporation of the latest evidence into clinical practice.

aimThis article introduces digital tools designed to enhance systematic review processes, emphasizing their functionality, availability, and independent validation in peer-reviewed literature.

methodsWe discuss digital evidence synthesis tools for systematic reviews, identifying tools for all review processes, tools for search strategy development, reference management, study selection, data extraction, and critical appraisal. Emphasis is on validated, functional tools with independently published method evaluations.

resultsTools like EPPI-Reviewer, Covidence, DistillerSR, and JBI-SUMARI provide comprehensive support for systematic reviews. Additional tools cater to evidence search (e.g., PubMed PICO, Trialstreamer), reference management (e.g., Mendeley), prioritization in study selection (e.g., Abstrackr, EPPI-Reviewer, SWIFT-ActiveScreener), and risk bias assessment (e.g., RobotReviewer). Machine learning and AI integration facilitate workflow efficiency but require end-user informed evaluation for their adoption.

conclusionThe development of digital tools, particularly those incorporating AI, represents a significant advancement in systematic review methodology. These tools not only support the systematic review process but also have the potential to improve the timeliness and quality of evidence available for decision-making. The findings are relevant to clinicians, researchers, and those involved in the production or support of systematic reviews, with broader applicability to other research methods.

Indexed as

Systematic Reviews as TopicArtificial IntelligenceHumansSoftwareartificial intelligenceautomation toolsmachine‐learningpathologysystematic review automation

Identifiers

PMID40290054
PMCPMC12035789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.